Traveka Wealth’s Eli Lilly LLY Stock Holding History

Traveka Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83M	Buy	2,362 +36	+2%	+$36.8K	0.94%	25
2026 Q1	$2.14M	Buy	2,326 +26	+1%	+$26.4K	0.82%	29
2025 Q4	$2.47M	Sell	2,300 -102	-4%	-$97.5K	1.01%	24
2025 Q3	$1.83M	Sell	2,402 -40	-2%	-$29.8K	0.82%	32
2025 Q2	$1.9M	Sell	2,442 -148	-6%	-$115K	1.01%	28
2025 Q1	$2.14M	Sell	2,590 -1,325	-34%	-$1.1M	1.2%	21
2024 Q4	$3.02M	Buy	3,915 +1,213	+45%	+$1M	1.67%	18
2024 Q3	$2.39M	Sell	2,702 -447	-14%	-$402K	1.22%	22
2024 Q2	$2.85M	Buy	3,149 +112	+4%	+$89.6K	1.39%	20
2024 Q1	$2.36M	Sell	3,037 -1,143	-27%	-$813K	1.09%	25
2023 Q4	$2.44M	Buy	+4,180	New	+$2.44M	1.23%	23

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Traveka Wealth's LLY Position: Q2 2026 in Review

Traveka Wealth increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $36.8K and bringing the position to 2,362 shares worth $2.83M. The position accounts for 0.94% of the portfolio, ranked #25.

Traveka Wealth first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.02M in Q4 2024. 2,373 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Traveka Wealth held 2,362 shares of Eli Lilly worth $2.83M as of Q2 2026.
Traveka Wealth bought 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
Eli Lilly made up 0.94% of Traveka Wealth's portfolio in Q2 2026, its #25 holding.
Traveka Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
Traveka Wealth's Eli Lilly position peaked at $3.02M in Q4 2024.
2,373 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.